Background--Hypertension is the major risk factor for cardiovascular disease, the most common cause of death worldwide. Resistance arteries are capable of adapting their diameter independently in response to pressure and flow-associated shear stress. Ryanodine receptors (RyRs) are major Ca 2+ -release channels in the sarcoplasmic reticulum membrane of myocytes that contribute to the regulation of contractility. Vascular smooth muscle cells exhibit 3 different RyR isoforms (RyR1, RyR2, and RyR3), but the impact of individual RyR isoforms on adaptive vascular responses is largely unknown. Herein, we generated tamoxifen-inducible smooth muscle cell-specific RyR2-deficient mice and tested the hypothesis that vascular smooth muscle cell RyR2s play a specific role in elementary Ca 2+ signaling and adaptive vascular responses to vascular pressure and/or flow.
A rteries adapt to hemodynamic forces through changes in their diameter. These adaptive responses take 2 forms that reflect the operation of 2 independent mechanisms: (1) a decrease in vessel diameter in response to increased transmural pressure, a response termed myogenic constriction (or Bayliss effect) that is intrinsic to smooth muscle (SM) myocytes; and (2) an increase in vessel diameter in response to increased blood flow, reflecting the short-and long-term action of shear stress on the vessel wall, the latter of which reflects outward remodeling of the vascular SM cell (VSMC) layers. 1 In arterial SM cells (SMCs), membrane depolarization produces a moderate (100-300 nmol/L) increase in intracel- 6, [11] [12] [13] [14] [15] The ability of RyRs to produce Ca 2+ sparks in VSMCs may depend on the RyR isoform. Mammals possess 3 subtypes of RyRs (RyR1, RyR2, and RyR3), each composed of >5000 amino acids with a total molecular mass of %565 kDa. [16] [17] [18] [19] The 3 RyRs show 66% to 70% overall amino acid identity, 20 and all 3 RyR isoforms are expressed in arterial SM. 21, 22 Coussin et al 23 suggested that both RyR1 and RyR2 contribute to spontaneous Ca 2+ sparks in cultured VSMCs from the portal vein, a suggestion supported by the observation that antisense oligonucleotides against RyR3 had no effect on spontaneous Ca 2+ spark activity. 24 Consistent with this, we previously showed that the peak amplitude, width, and duration of Ca 2+ sparks in freshly isolated cerebral VSMCs from RyR3-deficient (Ryr3 À/À ) mice were normal. 25 However, the frequency of Ca 2+ sparks was higher in RyR3-deficient
VSMCs than in wild-type cells, suggesting that RyR3 might play a role in modulating RyR1 and/or RyR2 function. A specific role of RyR1 in SR Ca 2+ release in pulmonary artery
VSMCs was suggested on the basis of the observation that hypoxia-induced increases in [Ca 2+ ] i and contraction were largely eliminated in Ryr1 +/-VSMCs. 26 However, results from global gene knockout mouse models are difficult to interpret because of possible confounding effects of compensatory mechanisms. In addition, the contributions of the RyR2 subtype to arterial elementary Ca 2+ signaling and adaptive responses in the vasculature remain unclear. Herein, we established the first tamoxifen-inducible, SMspecific RyR2-knockout (SM-Ryr2 À/À ) mouse model to test the hypothesis that RyR2 contributes to SR Ca 2+ release in arterial VSMCs. Unexpectedly, we found that the RyR2 isoform plays a dominant role in local and global VSMC SR Ca 2+ release in both systemic and pulmonary arteries. We further found that the expression of VSMC RyR2 is an essential prerequisite for the formation of Ca 2+ sparks, which limit arterial myogenic constriction to pressure. Furthermore, we found that RyR2 plays an important role in the pulmonary artery pressure response to sustained hypoxia but does not contribute to flow-induced increases in pulmonary arterial pressure. Finally, RyR2 does not contribute to postischemic recovery of blood flow in a hind limb occlusion model.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request.
Mouse Model
Animal care followed American Physiological Society guidelines. All animal protocols were approved by the local animal care committee (LAGeSo, Berlin, Germany) and the animal welfare officers of the Max Delbr€ uck Center for Molecular Medicine. There are no ethical concerns. Mice were maintained in individually ventilated cages (IVC, Techniplast, Germany) under standardized conditions with a 12-hour dark-light cycle and free access to standard chow (0.25% sodium; SSNIFF Spezialit€ aten, Soest, Germany) and drinking
Clinical Perspective
What Is New?
• Our study demonstrates a specific contribution of ryanodine receptor type 2 in mediating vascular smooth muscle cell Ca 2+ -release events relevant for regulating myogenic tone in the systemic circulation.
• We also found that ryanodine receptor type 2 provides a negative regulatory role in hypoxic vasoconstriction in the pulmonary circulation but does not contribute to postischemic recovery of blood flow conductance in the hind limb circulation.
What Are the Clinical Implications?
• These findings elucidate the role and mechanism of ryanodine receptor type 2 channels in myogenic constriction and in regulating adaptive reductions in arterial diameter in response to pressure, but not flow.
• Our study potentially offers new possibilities for therapeutic interventions in systemic and pulmonary hypertension.
water. SM-Ryr2 À/À conditional knockout mice were created by crossbreeding mice containing an Ryr2 gene containing a loxP-flanked region ( Figure 1A) Offermanns (Max-Planck-Institut f€ ur Herz-und Lungenforschung, Bad Nauheim, Germany).
Western Blot Analysis
Thoracic aortae and hearts were isolated from mice and placed into cold physiological saline solution (PSS) previously oxygenated for 30 minutes (95% O 2 , 5% CO 2 ). The composition of PSS (in mmol/L) was as follows: 119 NaCl, 4. 
RNA Isolation and Quantitative Reverse Transcription-Polymerase Chain Reaction
Total RNA was isolated from snap-frozen fat-free aortae using the RNeasy RNA isolation kit (Qiagen). RNA concentration and quality were measured using a NanoDrop-1000 spectrophotometer (PeqLab Biotechnologie, Germany). cDNA was synthesized by reverse transcription from 2 lg of total RNA (Applied Biosystems). Fluo-4 was excited with a krypton-argon laser at 488 nm, and the emitted fluorescence was collected at >500 nm. Each file was recorded for 30 to 60 seconds, and images were collected at a rate of 53 images/s. Imaging fields were 1319131 lm (2569256 pixels). 33 The diameter of pressurized arteries was monitored, as previously described. 34 
Isolation of Arterial VSMCs
VSMCs from tibial and mesenteric arteries were isolated, as described. 12, 14 Briefly, arteries were removed and quickly transferred to cold (4°C), oxygenated (95% O 2 -5% CO 2 ) PSS. The arteries were then cleaned, cut into pieces, and incubated for 50 minutes at 37°C in Ca 2+ -free Hank's solution consisting of the following (in mmol/L): 55 NaCl, 80 sodium glutamate, 5.6 KCl, 2 MgCl 2 , 10 glucose, and 10 HEPES (pH 7.4 with NaOH) containing 1 mg/mL BSA (Sigma, Taufkirchen, Germany), 0.5 mg/mL papain (Sigma), and 1.0 mg/ mL dithiothreitol. The segments were then placed in Hank's solution containing 1 mg/mL collagenase (types F and H; ratio, 30% and 70%, respectively; Sigma) and 0.1 mmol/L CaCl 2 for 10 minutes at 37°C. After several washes in Ca 2+ -free Hank's solution (containing 1 mg/mL BSA), single cells were dispersed from artery segments by gently triturating. Cells were then stored in the same solution at 4°C.
Ca 2+ Sparks
VSMCs were seeded onto glass coverslips and incubated with the Ca 2+ indicators Fluo-3-AM or Fluo-4-AM (10 lmol/L) and pluronic acid (0.005%, w/v) for 60 minutes on ice (in the same bath solution used for patch-clamp measurements). 30 After loading, the cells were washed with bath solution for at least 10 minutes at room temperature. Single SMCs were imaged (at 20-59 frames/s) using a Nipkow disc-based UltraView LCI confocal scanner (Perkin Elmer, Waltham, MA) linked to a fast digital camera. The confocal system was mounted on an inverted Diaphot microscope with a 940 oilimmersion objective (numerical aperture, 
Telemetry
Radiotelemetric blood pressure measurements were performed on adult C57Bl6 SM-Ryr2 À/À mice, as described elsewhere. 37 After implanting blood pressure devices, mice were allowed %2 weeks to recover from surgery and exhibit regular diurnal activity rhythms. Targeted deletion of Ryr2 was induced by administration of tamoxifen (see above).
Femoral Artery Occlusion Model and Assessment of Blood Flow by Laser Doppler Imaging
Occlusion of the right femoral artery in 12-week-old mice was performed, as described previously. 38 For repetitive assessment of hind limb blood flow after occlusion, we used the noninvasive laser Doppler imaging technique. 38 The laser 41 Second and third pressure-flow curves were generated during hypoxic pulmonary vasoconstriction phase 1 and phase 2, respectively. After 88 minutes of hypoxia, normoxic ventilation was reestablished and, after another steady-state period of 22 minutes, caffeine (10 mmol/L) was administered to the perfusate for 2 minutes; this latter step was repeated twice at 12-minute intervals.
Materials
Fluo-3-AM and Fluo-4-AM were purchased from Molecular Probes (Eugene, OR), and A23187 was from AppliChem (Darmstadt, Germany). The antibody against RyR2 was from Millipore/Chemicon (Schwalbach/Ts, Germany). All salts and other drugs were obtained from Sigma-Aldrich (Munich, Deisenhofen, or Schnelldorf, Germany) or Merck (Darmstadt, Germany). In cases in which dimethyl sulfoxide was used as a solvent, the maximal dimethyl sulfoxide concentration after application did not exceed 0.5%.
Statistical Analysis
Data are presented as meansAESEM. Descriptive statistics were calculated, and variables were examined for meeting assumptions of normal distribution without skewness and kurtosis by using quantile-quantile plot, 
Results

SM-Ryr2
À/À mice, generated by SMC-targeted deletion of the Ryr2 gene by tamoxifen-dependent Cre recombinase under the control of the endogenous SM22a gene locus ( Figure 1A ), showed virtually no detectable RyR2 mRNA in aortic, mesenteric, and tibial artery tissues compared with control mice and completely lacked RyR2 protein ( Figure 1B through 1D, Figure S1B and S1C).
RyR2s in Global SR Ca 2+ Release in Peripheral Arteries
We next studied the contribution of RyR2 to global SR Ca 2+ release and arterial contraction. SR Ca 2+ release was induced by the pan RyR activator caffeine (10 mmol/L). As shown in Figure 2A and 2B, caffeine induced strong contractions of the aorta and mesenteric, femoral, tibial, and cerebral arteries of control mice. In contrast, caffeine (10 mmol/L) was largely ineffective in inducing contraction in any of these arteries from SM-Ryr2 À/À mice (Figure 2A and 2B). These data indicate that the RyR2 isoform is the predominant contributor to SR Ca 2+ -release-induced contraction of peripheral arteries. lower), as measured by video microscopy using Fluo-4-AMloaded vessels. However, vascular contractions in response to the a 1 -adrenergic receptor agonist phenylephrine were normal in SM-Ryr2 À/À arteries in both Ca 2+ -containing PSS ( Figure 2D ) and Ca 2+ -free PSS ( Figure 2E ). These latter results indicate that RyR2 deficiency does not affect phenylephrine-induced contractions of VSMCs in mesenteric arteries. Figure 4A through 4C, which depicts fluorescence images of a representative Fluo-4-loaded cell. Two regions of interest (ROIs), denoted by yellow circles a and b (Figure 4A ), are highlighted; these correspond to nonspark and spark sites, respectively, as shown in Figure 4B . Continuous recordings of changes in fluorescence intensity over time revealed recurring Ca 2+ sparks in ROI b
RyR2s in Local Ca
( Figure 4C , highlighted in detail in the inset), but not in ROI a. Figure 4C also Figure 4D and 4G). Moreover, although the majority (87%) of VSMCs from control mice (Figure 4E and 4F). We confirmed our results using another transgenic mouse line in which Cre recombinase expression is driven by the SM myosin heavy chain promoter. 44 Reverse transcription-polymerase chain reaction showed that RyR2 mRNA was almost undetectable in aortic tissue, as well as mesenteric and tibial arteries, of SM myosin heavy chain-Ryr2 À/À mice compared with control mice ( Figure 5A) ; and tibial artery SMCs from these mice lacked Ca 2+ sparks (Figure 5B through 5H sparks activate a small number of proximate BK Ca channels to cause a transient outward current, traditionally referred to as STOCs. STOCs were recorded in tibial artery SMCs from control and SM-Ryr2 À/À mice using the patch-clamp technique (Figure 7) . A peak amplitude >28 pA above baseline, the criterion for a STOC at a holding potential of -20 mV, is 3 times the BK Ca single-channel current based on a conductance of 150 pS. 46 Figure 7A shows recordings from a control VSMC at À40, À20, and 0 mV, demonstrating the presence of STOCs at À20 mV and more positive membrane potentials. In contrast, STOCs were absent in VSMCs from SM-Ryr2 À/À mice ( Figure 7B ). At À20 mV, 48% of control cells (n=31) exhibited STOCs, whereas no SM-Ryr2 À/À VSMCs (n=25) exhibited STOCs ( Figure 7C ).
STOCs in control cells exhibited a frequency of 0.44AE0.14 Hz ( Figure 7D ) and a mean amplitude of 26.5AE6.0 pA at À20 mV ( Figure 7E ). Caffeine (10 mmol/L) induced a strong outward BK Ca current in control VSMCs ( Figure S3A) (Figure 8A and 8B).
RyR2s in the Myogenic Response of Peripheral Arteries
We next tested the function of the RyR2 Ca 2+ spark-BK Ca channel pathway in opposing vasoconstriction to elevated transmural pressure (myogenic tone). Isolated mesenteric arteries were pressurized to 80 mm Hg and allowed to develop myogenic tone with a functional Ca 2+ spark-BK Ca channel pathway 34 ( Figure 9 ). The viability of vessels was confirmed by measuring the contractile response to a depolarizing concentration of KCl (60 mmol/L). The degree of myogenic tone in pressurized arteries was expressed relative to maximum diameter, determined by exposure to Ca 2+ -free external PSS. 34 Inhibition of the Ca 2+ spark-BK Ca channel pathway with the RyR inhibitor ryanodine (10 lmol/ L) 48 increased myogenic constriction in wild-type (control) arteries ( Figure 9A ), consistent with previous reports. 6, 49 In contrast, ryanodine had almost no effect on the diameters of arteries from SM-Ryr2 À/À mice ( Figure 9B and 9C). These results indicate that the Ca 2+ spark-BK Ca channel pathway in VSMCs limits myogenic tone through RyR2s, without the involvement of other RyR isoforms.
RyR2s in the Pulmonary Circulation
In the lung, alveolar hypoxia leads to constriction of upstream pulmonary arterioles through retrograde signal transduction via gap junctions. 50 Using an ex vivo lung perfusion model, we investigated the role of VSMC RyR2s in the pulmonary artery pressure response to hypoxia. Basal mean pulmonary arterial pressure was not significantly different between control (10.3AE0.2 cm H 2 O) and SM-Ryr2 À/À (11.0AE0.3 cm H 2 O)
lungs. There was also no difference in pulmonary arterial pressure between control and SM-Ryr2 À/À lungs during the short-term phase of hypoxia (phase 1) (Figure 10A and 10B) . However, under sustained hypoxia (phase 2), the increase in Figure 10A and 10B).
This difference was observed over a wide range of flow rates (0.5-2.0 mL/min) ( Figure 10C) . Notably, flow-induced increases in mean pulmonary arterial pressure did not differ between the 2 groups under normoxic conditions or in the short-term phase of hypoxic pulmonary vasoconstriction ( Figure 10C ). These results argue for an important role of VSMC RyR2s in the sustained phase of hypoxic pulmonary vasoconstriction, but not in the short-term phase. It is unlikely that SR Ca 2+ release through VSMC RyR1 or RyR3 plays an important role in these effects because caffeine (10 mmol/L) induced a transient pulmonary vasoconstriction in control lungs, but not in SM-Ryr2 À/À lungs ( Figure 10D and 10E).
RyR2s in the Ischemic Hind Limb Circulation
RyRs may play a role in postischemic recovery of blood flow in the systemic peripheral circulation. [51] [52] [53] In this setting, the magnitude of collateral flow strongly depends on the shearstress-induced outward remodeling response of preexisting collateral arteries in the hind limb. 54, 55 To investigate the role of RyR2 in hind limb blood flow recovery after ligation of the femoral artery, we monitored perfusion of the right hind limb using the laser Doppler imaging technique and compared it with that in the intact left hind limb. There was no difference in blood flow recovery in the right hind limb in control compared with SM-Ryr2 À/À mice within 21 days after ligation (Figure 11 ). These results argue against an important role of RyR2 in postischemic recovery of blood flow. Changes in systemic blood pressure may mask the role of the gene(s) of interest in these effects. However, we found that tamoxifen induced only a 3-to 4-mm Hg increase in mean arterial blood pressure in SM-Ryr2 À/À mice ( Figure 12 ).
Discussion
Resistance arteries exhibit adaptive changes in their diameter in response to pressure and flow that are mediated by distinct mechanisms. 1 Increases in transluminal pressure trigger an adaptive reduction in diameter. This myogenic response, which serves to normalize perfusion, is triggered by stretchsensitive mechanisms that operate in VSMCs. 34 In contrast, increases in blood flow act via an increase in shear stress to trigger an increase in arterial diameter. Short-term increases in blood flow/shear stress result in arterial dilation through a mechanism that involves the endothelial-dependent NO pathway, whereas long-term exposure to elevated shear stress causes a structural increase in the arterial lumen. This adaptive response requires activation of matrix metalloproteases that allow remodeling of the SM layers. In the current 30 In the present study, we investigated the contribution of RyR2s to VSMCs and subsequent feedback regulation of myogenic tone in response to transmural pressure. We further found that RyR2s contribute to the pulmonary artery pressure response to sustained hypoxia but have no effect on flowinduced responses. Finally, we found that RyR2s do not contribute to postischemic recovery of blood flow conductance in the peripheral systemic circulation, as shown in a hind limb occlusion model.
VSMC RyR2s in Peripheral Arteries and Vascular Adaptation to Pressure
Our data show that RyR2 is the major RyR isoform responsible for Ca 2+ sparks in the VSMC Ca 2+ -release unit of systemic arteries. We reach this conclusion for several reasons. hypoxic pulmonary vasoconstriction, because inhibition of BK Ca channels by charybdotoxin (50 ng/mL [%10 nmol/L]) or iberiotoxin (100 nmol/L) does not decrease hypoxic pulmonary vasoconstriction, but instead enhances vasopressor responses to ventilatory hypoxia in rats 73 and rabbits. 74 In addition, mice lacking the BK Ca b1 subunit show normal pulmonary constriction to acute hypoxia. 75 Future studies should explore the mechanisms by which the RyR2 isoform plays a protective role in sustained hypoxic pulmonary vasoconstriction. Plasma membrane stretch-activated channels, 76 TRPC1/6 channels (transient receptor potential canonical channels), [77] [78] [79] NADPH oxidase (nicotinamide adenine dinucleotide phosphate oxidase), 80 and cytochrome P450-derived epoxyeicosatrienoic acids 75 are promising candidate molecules to investigate in this context.
VSMC RyR2s in Hind Limb Ischemia and Vascular Adaptive Responses to Blood Flow
To test if RyR2s affect shear stress-induced responses, we examined the remodeling of native hind limb collateral arteries. It is well established that long-term increases in shear stress trigger the opening and outward remodeling of these preexisting bypasses. 54, 55 An increase in the size of collateral arteries minimizes tissue injury and ischemia caused by vaso-occlusive diseases, such as atherosclerosis. Using the mouse hind limb femoral artery ligation model 38, 81 as an experimental model for monitoring collateral artery recruitment, flow and remodeling characteristics, and tissue ischemia in vivo, we found that SM-Ryr2 À/À mice and control mice showed comparable blood flow characteristics. We also observed a strong increase in collateral blood flow and collateral diameter in both mouse strains in the short-term phase as well as long-term (up to 3 weeks after occlusion). This lack of differences in functional blood flow recovery between the SM-Ryr2 À/À and wild-type scenario suggests that, in this time period, RyR2 is not involved in adaptive remodeling of the peripheral vasculature; it neither mediates an acute dilation on changes in flow nor contributes to shear stress-mediated changes in arterial structural properties. Thus, although RyR2s have clear effects on VSMC Ca 2+ sparks, shear-stress-induced remodeling in peripheral hind limb ischemia appears normal in their absence. This is in sharp contrast to mice that are presumed to have altered Ca v 1.2 channel expression, which affects tonic Ca 2+ influx into VSMCs. 81 These mice exhibit an almost complete absence of shear-stress-induced arterial remodeling and collateral blood flow. Taken together, our data point toward a specific contribution of RyR2s in mediating VSMC Ca 2+ sparks that is relevant to the regulation of myogenic tone (systemic circulation) and arterial remodeling in response to changes in pressure (lung model), but not flow.
In conclusion, RyR2 is the predominant functional RyR isoform involved in mediating Ca 2+ sparks in VSMCs of mice.
We found that SM-specific genetic ablation of Ryr2 substantially reduces Ca 2+ sparks, which, in turn, prevents BK Ca channel activation, thereby increasing myogenic constriction. We further established that VSMC RyR2s are important in regulating adaptive reductions in arterial diameter in response to pressure, but not flow. We also found that RyR2 provides a negative regulatory role in hypoxic vasoconstriction in the pulmonary circulation but does not contribute to postischemic recovery of blood flow conductance in the hind limb circulation. Our study potentially offers new possibilities for therapeutic interventions in systemic and pulmonary hypertension. 
